IDF President Praises India’s Efforts for Affordable Type 1 Diabetes Treatment

By A Staff Reporter

On World Diabetes Day, International Diabetes Federation (IDF) President, Prof. Peter Schwarz, highlighted the significance of accessible and affordable treatment for children diagnosed with Type 1 Diabetes. Speaking on the necessity of timely intervention, he emphasized that insulin—a primary and life-saving treatment for those with Type 1 Diabetes—must be consistently available at a price families can afford.

“Ensuring that children diagnosed with Type 1 Diabetes have accessibility to treatment, particularly insulin, is crucial for managing their health and enabling a normal quality of life,” said Prof. Schwarz. “I am immensely thankful to the government of India, which has been one of the frontrunners globally in securing accessible, affordable insulin for children with Type 1 Diabetes. This support makes a profound difference for families and children impacted by this lifelong condition.”

In India, where an estimated 200,000 children live with Type 1 Diabetes, ensuring consistent access to insulin can be challenging, especially for low-income families. However, recent initiatives have focused on making the treatment both accessible and affordable through various programs and partnerships. Prof. Schwarz praised India’s approach, noting that these efforts significantly enhance the lives of children managing diabetes, helping them avoid complications and lead healthier lives.

The IDF President further underscored the importance of expanding such initiatives worldwide, as diabetes diagnoses, especially in young people, continue to rise. On this World Diabetes Day, Prof. Schwarz’s message resonates with families, healthcare providers, and policymakers, reinforcing the need for collaborative efforts to make diabetes treatment accessible and affordable for all.